These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37935744)

  • 1. Association of elevated levels of peripheral complement components with cortical thinning and impaired logical memory in drug-naïve patients with first-episode schizophrenia.
    Yu H; Ni P; Tian Y; Zhao L; Li M; Li X; Wei W; Wei J; Wang Q; Guo W; Deng W; Ma X; Coid J; Li T
    Schizophrenia (Heidelb); 2023 Nov; 9(1):79. PubMed ID: 37935744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral complement is increased in schizophrenia and inversely related to cortical thickness.
    Ji E; Boerrigter D; Cai HQ; Lloyd D; Bruggemann J; O'Donnell M; Galletly C; Lloyd A; Liu D; Lenroot R; Weickert TW; Shannon Weickert C
    Brain Behav Immun; 2022 Mar; 101():423-434. PubMed ID: 34808287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the plasma complement system with brain volume deficits in bipolar and major depressive disorders.
    Yu H; Ni P; Tian Y; Zhao L; Li M; Li X; Wei W; Wei J; Du X; Wang Q; Guo W; Deng W; Ma X; Coid J; Li T
    Psychol Med; 2023 Oct; 53(13):6102-6112. PubMed ID: 36285542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of the peripheral serum complement protein levels and cognitive function in first-episode drug-naive patients with schizophrenia].
    Xia XW; Li LJ; Chen ZC; Qiu Y; Zhao JS; Wu JY; Liu T; Dai JM; Li ZN; Chen C; Han ZL; Wei QL
    Zhonghua Yi Xue Za Zhi; 2020 Oct; 100(39):3081-3085. PubMed ID: 33105959
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigation of peripheral complement factors across stages of psychosis.
    Laskaris L; Zalesky A; Weickert CS; Di Biase MA; Chana G; Baune BT; Bousman C; Nelson B; McGorry P; Everall I; Pantelis C; Cropley V
    Schizophr Res; 2019 Feb; 204():30-37. PubMed ID: 30527272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between Genotype and Peripheral Complement Proteins in First-Episode Psychosis: Evidences From C3 and C4.
    Chen Y; Zhao Z; Lin F; Wang L; Lin Z; Yue W
    Front Genet; 2021; 12():647246. PubMed ID: 34306006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability.
    Hatzimanolis A; Foteli S; Stefanatou P; Ntigrintaki AA; Ralli I; Kollias K; Nikolaou C; Gazouli M; Stefanis NC
    Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1219-1228. PubMed ID: 35532796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased cortical thickness in drug naïve first episode schizophrenia: in relation to serum levels of BDNF.
    Song X; Quan M; Lv L; Li X; Pang L; Kennedy D; Hodge S; Harrington A; Ziedonis D; Fan X
    J Psychiatr Res; 2015 Jan; 60():22-8. PubMed ID: 25282282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1 is associated with deficits in cognition and cerebral cortical thickness in first-episode schizophrenia.
    Pan S; Zhou Y; Yan L; Xuan F; Tong J; Li Y; Huang J; Feng W; Chen S; Cui Y; Yang F; Tan S; Wang Z; Tian B; Hong LE; Tan YL; Tian L
    J Psychiatry Neurosci; 2022; 47(2):E86-E98. PubMed ID: 35301253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement proteins are elevated in blood serum but not CSF in clinical high-risk and antipsychotic-naïve first-episode psychosis.
    Cropley VL; Kittel M; Heurich M; Föcking M; Leweke FM; Pantelis C
    Brain Behav Immun; 2023 Oct; 113():136-144. PubMed ID: 37437819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients.
    Butler AE; Moin ASM; Sathyapalan T; Atkin SL
    Cells; 2023 Aug; 12(15):. PubMed ID: 37566081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of complement gene-set polygenic risk score on brain volume and cortical measures in patients with psychotic disorders and healthy controls.
    Holland JF; Cosgrove D; Whitton L; Harold D; Corvin A; Gill M; Mothersill DO; Morris DW; Donohoe G
    Am J Med Genet B Neuropsychiatr Genet; 2020 Dec; 183(8):445-453. PubMed ID: 32918526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia.
    Wei Q; Yan W; Zhang R; Yang X; Xie S
    Ann Gen Psychiatry; 2022 Feb; 21(1):4. PubMed ID: 35144626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of reduced cortical thickness and psychopathological symptoms in patients with first-episode drug-naïve schizophrenia.
    Zhou H; Wang D; Cao B; Zhang X
    Int J Psychiatry Clin Pract; 2023 Mar; 27(1):42-50. PubMed ID: 36193901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of selective complement markers with schizophrenia.
    Mohd Asyraf AJ; Nour El Huda AR; Hanisah MN; Norsidah KZ; Norlelawati AT
    J Neuroimmunol; 2022 Feb; 363():577793. PubMed ID: 34990981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia.
    Molina V; Taboada D; Aragüés M; Hernández JA; Sanz-Fuentenebro J
    Schizophr Res; 2014 Sep; 158(1-3):223-9. PubMed ID: 25088730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions.
    North HF; Bruggemann J; Cropley V; Swaminathan V; Sundram S; Lenroot R; Pereira AM; Zalesky A; Bousman C; Pantelis C; Weickert TW; Shannon Weickert C
    Eur Arch Psychiatry Clin Neurosci; 2021 Jun; 271(4):595-607. PubMed ID: 33760971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Cortical Structures and Cognition in Antipsychotic-Naïve Patients With First-Episode Schizophrenia: A Partial Least Squares Correlation Analysis.
    Jessen K; Mandl RCW; Fagerlund B; Bojesen KB; Raghava JM; Obaid HG; Jensen MB; Johansen LB; Nielsen MØ; Pantelis C; Rostrup E; Glenthøj BY; Ebdrup BH
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 May; 4(5):444-453. PubMed ID: 30420252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls.
    Jacomb I; Stanton C; Vasudevan R; Powell H; O'Donnell M; Lenroot R; Bruggemann J; Balzan R; Galletly C; Liu D; Weickert CS; Weickert TW
    Front Immunol; 2018; 9():2230. PubMed ID: 30364161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement Gene Expression Correlates with Superior Frontal Cortical Thickness in Humans.
    Allswede DM; Zheutlin AB; Chung Y; Anderson K; Hultman CM; Ingvar M; Cannon TD
    Neuropsychopharmacology; 2018 Feb; 43(3):525-533. PubMed ID: 28758643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.